We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation].
- Authors
Thachil, Jecko; Toh, Cheng Hok; Levi, Marcel; Watson, Henry G
- Abstract
The article comments on the withdrawal of activated protein c from the use in patients with severe sepsis and disseminated intravascular coagulation (DIC). As stated, this is an amendment to the guidelines issued by the British Committee for Standards in Haematology (BCSH) on disseminated intravascular coagulation. It states that Eli Lilly & Co. wich manufactures it has decided to withdraw the product from the market worldwide.
- Publication
British Journal of Haematology, 2012, Vol 157, Issue 4, p493
- ISSN
0007-1048
- Publication type
Academic Journal
- DOI
10.1111/j.1365-2141.2011.09019.x